187 related articles for article (PubMed ID: 35673816)
1. MLH1, BRAF and p53 - searching for significant markers to predict evolution towards adenocarcinoma in colonic sessile serrated lesions.
Răduţă D; Dincă OM; Micu GV; Nichita L; Cioplea MD; Buşcă RM; Ardeleanu R; Mateescu RB; Benguş A; Zurac SA; Popp CG; Vlădan GC
Rom J Morphol Embryol; 2021; 62(4):971-979. PubMed ID: 35673816
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological and molecular features of sessile serrated adenomas with dysplasia or carcinoma.
Bettington M; Walker N; Rosty C; Brown I; Clouston A; McKeone D; Pearson SA; Leggett B; Whitehall V
Gut; 2017 Jan; 66(1):97-106. PubMed ID: 26475632
[TBL] [Abstract][Full Text] [Related]
3. MLH1-deficient Colorectal Carcinoma With Wild-type BRAF and MLH1 Promoter Hypermethylation Harbor KRAS Mutations and Arise From Conventional Adenomas.
Farchoukh L; Kuan SF; Dudley B; Brand R; Nikiforova M; Pai RK
Am J Surg Pathol; 2016 Oct; 40(10):1390-9. PubMed ID: 27438990
[TBL] [Abstract][Full Text] [Related]
4. BRAF V600E immunohistochemistry demonstrates that some sessile serrated lesions with adenomatous dysplasia may represent collision lesions.
Bettington M; Liu C; Gill A; Walker N; Leggett B; Whitehall V; Rosty C
Histopathology; 2019 Jul; 75(1):81-87. PubMed ID: 30825335
[TBL] [Abstract][Full Text] [Related]
5. MLH1-93 G/a polymorphism is associated with MLH1 promoter methylation and protein loss in dysplastic sessile serrated adenomas with BRAF
Fennell LJ; Jamieson S; McKeone D; Corish T; Rohdmann M; Furner T; Bettington M; Liu C; Kawamata F; Bond C; Van De Pols J; Leggett B; Whitehall V
BMC Cancer; 2018 Jan; 18(1):35. PubMed ID: 29304767
[TBL] [Abstract][Full Text] [Related]
6. Phenotype and polyp landscape in serrated polyposis syndrome: a series of 100 patients from genetics clinics.
Rosty C; Buchanan DD; Walsh MD; Pearson SA; Pavluk E; Walters RJ; Clendenning M; Spring KJ; Jenkins MA; Win AK; Hopper JL; Sweet K; Frankel WL; Aronson M; Gallinger S; Goldblatt J; Woodall S; Arnold J; Walker NI; Jass JR; Parry S; Young JP
Am J Surg Pathol; 2012 Jun; 36(6):876-82. PubMed ID: 22510757
[TBL] [Abstract][Full Text] [Related]
7. RNF43 germline and somatic mutation in serrated neoplasia pathway and its association with BRAF mutation.
Yan HHN; Lai JCW; Ho SL; Leung WK; Law WL; Lee JFY; Chan AKW; Tsui WY; Chan ASY; Lee BCH; Yue SSK; Man AHY; Clevers H; Yuen ST; Leung SY
Gut; 2017 Sep; 66(9):1645-1656. PubMed ID: 27329244
[TBL] [Abstract][Full Text] [Related]
8. [Immunophenotypes and gene mutations in colorectal precancerous lesions and adenocarcinoma].
Huang WT; Qiu T; Ling Y; Shi SS; Guo L; Zheng B; Lü N; Ying JM
Zhonghua Bing Li Xue Za Zhi; 2013 Oct; 42(10):655-9. PubMed ID: 24433726
[TBL] [Abstract][Full Text] [Related]
9. Serrated polyps of the large intestine: a molecular study comparing sessile serrated adenomas and hyperplastic polyps.
Sandmeier D; Benhattar J; Martin P; Bouzourene H
Histopathology; 2009 Aug; 55(2):206-13. PubMed ID: 19694828
[TBL] [Abstract][Full Text] [Related]
10. Molecular Profiling Based on KRAS/BRAF Mutation, Methylation, and Microsatellite Statuses in Serrated Lesions.
Sugai T; Eizuka M; Fujita Y; Kawasaki K; Yamamoto E; Ishida K; Yamano H; Suzuki H; Matsumoto T
Dig Dis Sci; 2018 Oct; 63(10):2626-2638. PubMed ID: 29974407
[TBL] [Abstract][Full Text] [Related]
11. Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway.
Kim JH; Bae JM; Cho NY; Kang GH
Oncotarget; 2016 Mar; 7(12):14095-111. PubMed ID: 26883113
[TBL] [Abstract][Full Text] [Related]
12. Externalization of saw-tooth architecture in small serrated polyps implies the presence of methylation of IGFBP7.
Kaji E; Uraoka T; Kato J; Hiraoka S; Suzuki H; Akita M; Saito S; Tanaka T; Ohara N; Yamamoto K
Dig Dis Sci; 2012 May; 57(5):1261-70. PubMed ID: 22173745
[TBL] [Abstract][Full Text] [Related]
13. The earliest events in BRAF-mutant colorectal cancer: exome sequencing of sessile serrated lesions with a tiny focus dysplasia or cancer reveals recurring mutations in two distinct progression pathways.
Bleijenberg AG; IJspeert JE; Mulder JB; Drillenburg P; Stel HV; Lodder EM; Carvalho B; Jansen J; Meijer G; van Eeden S; Dekker E; van Noesel CJ
J Pathol; 2022 Jun; 257(2):239-249. PubMed ID: 35143042
[TBL] [Abstract][Full Text] [Related]
14. BRAF, KRAS and PIK3CA mutations in colorectal serrated polyps and cancer: primary or secondary genetic events in colorectal carcinogenesis?
Velho S; Moutinho C; Cirnes L; Albuquerque C; Hamelin R; Schmitt F; Carneiro F; Oliveira C; Seruca R
BMC Cancer; 2008 Sep; 8():255. PubMed ID: 18782444
[TBL] [Abstract][Full Text] [Related]
15. Defined morphological criteria allow reliable diagnosis of colorectal serrated polyps and predict polyp genetics.
Rau TT; Agaimy A; Gehoff A; Geppert C; Jung K; Knobloch K; Langner C; Lugli A; Groenbus-Lurkin I; Nagtegaal ID; Rüschoff J; Saegert X; Sarbia M; Schneider-Stock R; Vieth M; Zwarthoff EC; Hartmann A
Virchows Arch; 2014 Jun; 464(6):663-72. PubMed ID: 24728704
[TBL] [Abstract][Full Text] [Related]
16. Molecular and histologic considerations in the assessment of serrated polyps.
Yang HM; Mitchell JM; Sepulveda JL; Sepulveda AR
Arch Pathol Lab Med; 2015 Jun; 139(6):730-41. PubMed ID: 26030242
[TBL] [Abstract][Full Text] [Related]
17. NTRK oncogenic fusions are exclusively associated with the serrated neoplasia pathway in the colorectum and begin to occur in sessile serrated lesions.
Kim JH; Hong JH; Choi YL; Lee JA; Seo MK; Lee MS; An SB; Sung MJ; Cho NY; Kim SS; Shin YK; Kim S; Kang GH
J Pathol; 2021 Dec; 255(4):399-411. PubMed ID: 34402529
[TBL] [Abstract][Full Text] [Related]
18. A comprehensive study of nondysplastic and dysplastic serrated polyps of the vermiform appendix.
Yantiss RK; Panczykowski A; Misdraji J; Hahn HP; Odze RD; Rennert H; Chen YT
Am J Surg Pathol; 2007 Nov; 31(11):1742-53. PubMed ID: 18059232
[TBL] [Abstract][Full Text] [Related]
19. Traditional serrated adenoma-like lesions in patients with inflammatory bowel disease.
Miller GC; Liu C; Bettington ML; Leggett B; Whitehall VLJ; Rosty C
Hum Pathol; 2020 Mar; 97():19-28. PubMed ID: 31917154
[TBL] [Abstract][Full Text] [Related]
20. KRAS and BRAF mutations and MSI status in precursor lesions of colorectal cancer detected by colonoscopy.
Yamane LS; Scapulatempo-Neto C; Alvarenga L; Oliveira CZ; Berardinelli GN; Almodova E; Cunha TR; Fava G; Colaiacovo W; Melani A; Fregnani JH; Reis RM; Guimarães DP
Oncol Rep; 2014 Oct; 32(4):1419-26. PubMed ID: 25050586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
